文献速递血栓与止血

无保险和弱势群体癌症患者的静脉血栓栓塞风险、治疗及结局模式

Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations.
PubMed 文献 · Am J Hematol · 2022-06-17

本研究为回顾性队列研究,纳入2011至2020年Harris Health System新诊断癌症患者15342例,其中74%无保险、84%居住于社会经济弱势社区。1年癌症相关血栓(CAT)发生率为14.6%;西班牙裔较非西班牙裔白人总体VTE风险更低(SHR 0.87),亚裔/太平洋岛民更低(SHR 0.58),非西班牙裔黑人PE/LE-DVT风险更高(SHR 1.18)。

要点

  • 无保险和弱势群体癌症患者1年CAT发生率为14.6%。
  • 西班牙裔较非西班牙裔白人总体VTE风险更低(SHR 0.87)。
  • 非西班牙裔黑人较非西班牙裔白人PE/LE-DVT风险更高(SHR 1.18)。

核心结论

  • 在大型医疗服务不足癌症患者队列中,CAT发生率较高,并识别出已知和新的风险预测因素。
  • 西班牙裔患者的校正后CAT发生率和死亡率更低。
  • 研究结果强调需要在临床试验中纳入弱势群体。

研究设计与样本

  • 回顾性队列研究,纳入2011至2020年Harris Health System新诊断癌症患者15342例,该机构为休斯顿大都会区无保险居民提供医疗服务。
  • 提取人口学、NCI合并症指数、区域剥夺指数(ADI)、癌症组织学、分期和全身治疗数据。
  • CAT定义为诊断后1年内总体静脉血栓栓塞(VTE)或肺栓塞±下肢深静脉血栓(PE/LE-DVT)。
  • 采用多因素Fine-Gray模型评估CAT相关因素,将死亡作为竞争风险。

主要发现

  • 15342例患者中74%无保险,84%居住于社会经济弱势社区;16%为非西班牙裔白人(NHW),28%为非西班牙裔黑人(NHB),50%为西班牙裔(27%为墨西哥裔),6%为亚裔/太平洋岛民(API)。
  • 1年CAT发生率为14.6%。
  • 西班牙裔较NHW总体VTE风险更低(SHR 0.87 [0.76-0.99]),API较NHW更低(SHR 0.58 [0.44-0.77])。
  • NHB较NHW的PE/LE-DVT风险更高(SHR 1.18 [1.01-1.39])。
  • CAT还与含化疗方案(±免疫治疗)、年龄、肥胖、癌症类型/分期、VTE病史和近期住院相关;NCI合并症指数和ADI评分与死亡率相关,但与CAT无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The epidemiology of cancer-associated thrombosis (CAT) among uninsured and vulnerable populations in the US is not well-characterized. We performed a retrospective cohort study for patients with newly diagnosed cancer from 2011 to 2020 at Harris Health System, which cares for uninsured residents in the Houston metropolitan area. Patient demographics, NCI comorbidity index, area of deprivation index (ADI), cancer histology, staging, and systemic therapy data were extracted. CAT included overall venous thromboembolism (VTE) or pulmonary embolism +/- lower extremity deep vein thrombosis (PE/LE-DVT) within 1 year of diagnosis. We used multivariable Fine-Gray models to assess the associations with CAT accounting for death as a competing risk. Among 15 342 patients, 74% were uninsured and 84% lived in socioeconomically disadvantaged neighborhoods. There were 16% Non-Hispanic White (NHW), 28% Non-Hispanic Black (NHB), 50% Hispanic (27% Mexican), and 6% Asian/Pacific Islanders (API). The 1-year CAT incidence rate was 14.6%. Overall VTE was lower for Hispanics versus NHW (SHR 0.87 [0.76-0.99]) and API versus NHW (SHR 0.58 [0.44-0.77]). PE/LE-DVT was higher for NHB versus NHW (SHR 1.18 [1.01-1.39]). CAT was also associated with chemotherapy-based regimens (+/- immunotherapy), age, obesity, cancer type/staging, VTE history, and recent hospitalization. NCI comorbidity and ADI scores were associated with mortality but not CAT. In a large cohort of underserved patients with cancer, we identified an elevated incidence of CAT with known and novel risk predictors. Hispanics had lower adjusted rates of CAT and mortality. Our findings highlight the need to investigate and incorporate vulnerable populations in clinical trials.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. da Costa WL, Guffey D, Oluyomi A, et al. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol. 2022. PMID: 35638475. doi:10.1002/ajh.26623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。